|
Suarez-Cortes M, Juan-Perez A, Molina-Rodriguez A, Araujo de Castro J, Castano-Molina MA, Fernandez-Ruiz VE, Jimenez-Mendez A, Martinez Perez-Munar P, Rico-Chazarra S, Ramos-Molina B, Sanchez-Solis M, Blanco-Carnero JE, Ruiz-Alcaraz AJ, Nunez-Sanchez MA. Dynamics of the Epigenome, Microbiome, and Metabolome in Relation to Early Adiposity in the Maternal-Infant Axis: Protocol for a Prospective, Observational Pilot Study in the Spanish NEMO Cohort. J Clin Med. 2025 Sep 23;14(19):6694. doi: 10.3390/jcm14196694. PubMed PMID: 41095773.
AÑO: 2025; IF: 2.9
|
41095773
|
Colosimo S, Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Nunez-Sanchez MA, Ferrer-Gomez M, Frutos MD, Tomlinson JW, Bertoli S, Marchesini G, Ramos-Molina B. A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study. Nutr Metab Cardiovasc Dis. 2024 May;34(5):1142-1145. doi: 10.1016/j.numecd.2023.12.008. Epub 2023 Dec 16. PubMed PMID: 38220504.
AÑO: 2024; IF: 3.7
|
|
Ruiz-Alcaraz AJ, Baquero L, Perez-Munar PM, Oliva-Bolarin A, Sanchez-Martinez MA, Ramos-Molina B, Nunez-Sanchez MA, Moreno DA. In Vitro Study of the Differential Anti-Inflammatory Activity of Dietary Phytochemicals upon Human Macrophage-like Cells as a Previous Step for Dietary Intervention. Int J Mol Sci. 2024 Oct 5;25(19):10728. doi: 10.3390/ijms251910728. PubMed PMID: 39409057; PubMed Central PMCID: PMC11477078.
AÑO: 2024; IF: 4.9
|
|
Castellano-Castillo D, Nunez-Sanchez MA, Balaguer-Roman A, Martinez-Sanchez MA, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez CM, Frutos MD, Queipo-Ortuno MI, Cardona F, Ramos-Molina B. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes. Surg Obes Relat Dis. 2024 Jul;20(7):652-659. doi: 10.1016/j.soard.2024.01.017. Epub 2024 Feb 6. PubMed PMID: 38490825.
AÑO: 2024; IF: 3.8
|
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Ramos-Molina B. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation through gut microbiota modulation as a novel therapeutic approach against anastomotic leak after colorectal cancer surgery. J Gastrointest Oncol. 2024 Oct 31;15(5):2338-2342. doi: 10.21037/jgo-24-314. Epub 2024 Oct 14. No abstract available. PubMed PMID: 39554579; PubMed Central PMCID: PMC11565100.
AÑO: 2024; IF: 2.0
|